Reuters: Study of hormone therapy shows some risks persist

[NaDiNe]

Study of hormone therapy shows some risks persist
      

CHICAGO (Reuters) - A follow-up analysis of women taking hormone replacement therapy found that their heightened risk of breast cancer persisted even after they stopped taking the drug combination, researchers said on Tuesday.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login